Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis

Journal of Virology

Volumn 83, Issue 9, 2009, Pages 4275-4286

  Schäfer, Alexandra ^a,b   Whitmore, Alan C ^a   Konopka, Jennifer L ^a,c   Johnston, Robert E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE STRUCTURE; IMMUNE RESPONSE; INNATE IMMUNITY; INOCULATION; MICROGLIA; MONOCYTE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REPLICON; STRUCTURAL GENE; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS ENCEPHALITIS; WILD TYPE;

ANIMALS; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED BALB C; MICROGLIA; RNA, VIRAL; VIRION;

MURINAE; MUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 66149147382     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02383-08     Document Type: Article

References (62)

1. Abbott, N. J., L. Rönnbäck, and E. Hansson. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7:41-53. (Pubitemid 41828930)
2. Allan, S. M., and N. J. Rothwell. 2001. Cytokines and neurodegeneration. Nat. Rev. Neurosci. 2:734-744. (Pubitemid 33674819)
3. Aloisi, F. 2001. Immune function of microglia. Glia 36:165-179.
4. Ambrosini, E., and F. Aloisi. 2004. Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 29:1017-1038.
5. Aronson, J. F., F. B. Grieder, N. L. Davis, P. C. Charles, T. Knott, K. Brown, and R. E. Johnston. 2000. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Virology 270:111-123.
6. Bergmann, C. C., T. E. Lane, and S. A. Stohlman. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4:121-132.
7. + leukocyte population. J. Immunol. 180:6760-6767.
8. Byrnes, A. P., J. E. Durbin, and D. E. Griffin. 2000. Control of Sindbis virus infection by antibody in interferon-deficient mice. J. Virol. 74:3905-3908. (Pubitemid 30180335)
9. Carson, M. J., J. M. Doose, B. Melchior, C. D. Schmid, and C. C. Ploix. 2006. CNS immune privilege: hiding in plain sight. Immunol. Rev. 213:48-65.
10. Charles, P. C., E. Walters, F. Margolis, and R. E. Johnston. 1995. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology 208:662-671.
11. Charles, P. C., J. Trgovcich, N. L. Davis, and R. E. Johnston. 2001. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Virology 284:190-202.
12. Chen, B. P., W. A. Kuziel, and T. E. Lane. 2001. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J. Immunol. 167:4585-4592. (Pubitemid 32954338)
13. Delhaye, S., S. Paul, G. Blakqori, M. Minet, F. Weber, P. Staeheli, and T. Michiels. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. USA 103:7835-7840.
14. Dietrich, J. B. 2002. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J. Neuroimmunol. 128:58-68. (Pubitemid 34722364)
15. Fabis, M. J., G. S. Scott, R. B. Kean, H. Koprowski, and D. C. Hooper. 2007. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knock out mice models. Proc. Natl. Acad. Sci. USA 104:5656-5661.
16. Fabry, Z., C. S. Raine, and M. N. Hart. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:218-224.
17. Fischer, H. G., and G. Reichmann. 2001. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166:2717-2726. (Pubitemid 32173513)
18. Ford, A. A. L. Goodsall, W. F. Hickey, and J. D. Sedgwick. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. J. Immunol. 154:4309-4321.
19. Glass, W. G., M. J. Hickey, J. L. Hardison, M. T. Liu, J. E. Manning, and T. E. Lane. 2004. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J. Immunol. 172:4018-4025. (Pubitemid 38375213)
20. Gleiser, C. A., W. S. Gochenour, Jr., T. O. Berge, and W. D. Tigertt. 1962. The comparative pathology of experimental Venezuelan equine encephalomyelitis infection in different animal hosts. J. Infect. Dis. 110:80-97.
21. Grieder, F. B., N. L. Davis, J. F. Aronson, P. C. Charles, D. C. Sellon, K. Suzuki, and R. E. Johnston. 1995. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology 206:994-1006.
22. Grieder, F. B., B. K. Davis, X. D. Zhou, S. J. Chen, F. D. Finkelman, and W. C. Gause. 1997. Kinetic of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology 233:302-312.
23. Griffin, D. E. 2001. Alphaviruses, p. 917-962. In D. M. Knipe, B. N. Fields, and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
24. Griffin, D. E. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3:493-502. (Pubitemid 37339189)
25. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118-124.
26. Hooper, D. C., G. S. Scott, A. Zborek, T. Mikheeva, R. B. Kean, H. Koprowski, and S. V. Spitsin. 2000. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 14:691-698.
27. Jackson, A. C., and J. P. Rossiter. 1997. Apoptotic cell death is an important cause of neuronal injury in experimental Venezuelan equine encephalitis virus infection of mice. Acta Neuropathol. 93:349-353. (Pubitemid 27153701)
28. Jordan, G. W. 1973. Interferon sensitivity of Venezuelan equine encephalomyelitis virus. Infect. Immun. 7:911-917.
29. Konopka, J. L., L. O. Penalva, J. M. Thompson, L. J. White, C. W. Beard, J. D. Keene, and R. E. Johnston. 2007. A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo. PLoS Pathog. 3:e199.
30. Liu, M. T., B. P. Chen, P. Oertel, M. J. Buchmeier, D. Armstrong, T. A. Hamilton, and T. E. Lane. 2000. Cutting edge: the T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 165:2327-2330.
31. Malone, K. E., S. A. Stohlman, C. Ramakrishna, W. Macklin, and C. C. Bergmann. 2008. Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis. Glia 56:426-435.
32. Mayhan, W. G. 2002. Cellular mechanism by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res. 927:144-152. (Pubitemid 34124121)
33. Morrison, T. E., A. C. Whitmore, R. S. Shabman, B. A. Lidbury, S. Mahalingam, and M. T. Heise. 2006. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J. Virol. 80:737-749. (Pubitemid 43062886)
34. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagl, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
35. Neumann, H. 2001. Control of glial immune function by neurons. Glia 36:191-199.
36. Niederkorn, J. Y. 2006. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7:354-359.
37. Olson, J. K., and S. D. Miller. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:3916-3924. (Pubitemid 39280755)
38. Perry, V. H., C. Cunningham, and C. Holmes. 2007. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7:161-167. (Pubitemid 46174862)
39. Phares, T. W., R. B. Kean, T. Mikheeva, and D. C. Hooper. 2006. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. 176:7666-7675. (Pubitemid 43849067)
40. Ponomarev, E. D., L. P. Shriver, K. Maresz, and B. N. Dittel. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81:374-389. (Pubitemid 41359292)
41. Préhaud, C., F. Mégret, M. Lafage, and M. Lafon. 2005. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79:12893-12904. (Pubitemid 41433208)
42. Pushko, P., M. Parker, G. V. Ludwig, N. L. Davis, R. E. Johnston, and J. F. Smith. 1997. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239:389-401.
43. Ransohoff, R. M., A. Glabinski, and M. Tani. 1996. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7:35-46. (Pubitemid 27202664)
44. Ransohoff, R. M., P. Kivisäkk, and G. Kidd. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3:569-581. (Pubitemid 37328676)
45. Rebenko-Moll, N. M., L. Liu, A. Cardona, and R. M. Ransohoff. 2006. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 18:683-689.
46. Ryman, K., W. Klimstra, K. Nguyen, C. Biron, and R. E. Johnston. 2000. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74:3366-3378. (Pubitemid 30143762)
47. Ryzhikov, A. B., E. I. Ryabchikova, A. N. Sergeev, and N. V. Tkacheva. 1995. Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch. Virol. 140:2243-2254. (Pubitemid 3020065)
48. Samuel, M. A., and M. S. Diamond. 2006. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80:9349-9360.
49. Santambrogio, L., S. L. Belyanskaya, F. R. Fischer, B. Cipriani, C. F. Brosnan, P. Ricciardi-Castagnoli, L. J. Stern, J. L. Strominger, and R. Riese. 2001. Developmental plasticity of CNS microglia. Proc. Natl. Acad. Sci. USA 98:6295-6300.
50. Schoneboom, B. A., M. J. Fultz, T. H. Miller, L. C. McKinney, and F. B. Grieder. 1999. Astrocytes as targets for Venezuelan equine encephalitis virus infection. J. Neurovirol. 5:342-354. (Pubitemid 29391115)
51. Sedgwick, J. D., S. Schwender, H. Imrich, R. Dörries, G. W. Butcher, and V. terMeulen. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA 88:7438-7442.
52. Shrikant, P., and E. N. Beneveniste. 1996. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 157:1819-1822.
53. Spotts, D. R., R. M. Reich, M. A. Kalkhan, R. M. Kinney, and J. T. Roehrig. 1998. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5′ noncoding region and glycoproteins. J. Virol. 72:10286-10291.
54. Tenenbaum, S. A., C. C. Carson, P. J. Lager, and J. D. Keeene. 2000. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc. Natl. Acad. Sci. USA 97:14085-14090.
55. +-T-cell effector function and migration following viral infection. J. Virol. 77:4004-4014.
56. Vogel, P., D. Abplanalp, W. Kell, M. S. Ibrahim, M. B. Downs, W. D. Pratt, and K. J. Davis. 1996. Venezuelan equine encephalitis in BALB/c mice: kinetic analysis of central nervous infection following aerosol or subcutaneous inoculation. Arch. Pathol. Lab. Med. 120:164-172.
57. Wang, E., R. A. Bowen, G. Medina, A. M. Powers, W. Kang, L. M. Chandler, R. E. Shope, and S. C. Weaver. 2001. Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains. Am. J. Trop. Med. Hyg. 65:64-69. (Pubitemid 32730367)
58. Wang, P., J. Dai, F. Bai, K.-F. Kong, S. J. Wong, R. R. Montgomery, J. A. Madri, and E. Fikrig. 2008. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J. Virol. 82:8978-8985.
59. Wang, T., T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig, and R. A. Flavell. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366-1373. (Pubitemid 40022719)
60. Weaver, S. C., C. Ferro, R. Barrera, J. Boshell, and J.-C. Navarro. 2004. Venezuelan equine encephalitis. Annu. Rev. Entomol. 49:141-174. (Pubitemid 38192420)
61. White, L. J., J.-G. Wang, N. L. Davis, and R. E. Johnston. 2001. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5′ untranslated region. J. Virol. 75:3706-3718.
62. Zhou, J., N. W. Marten, C. C. Bergmann, W. B. Macklin, D. R. Hinton, and S. A. Stohlman. 2005. Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J. Virol. 79:4764-4773. (Pubitemid 40464227)